Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants

Stock Track

05/05

Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.

The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.

Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1156798443"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156798443\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156798443?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156798443","market":"nz","top_or_hot":-1,"title":"Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants","media":"Stock Track","content":"<p>Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.</p><p>The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.</p><p>Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-05 21:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.</p><p>The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.</p><p>Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1156798443","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156798443","pubTimestamp":1777988697,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.The surge comes after multiple investment firms upgraded their...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"个股追踪|Twist Bioscience因分析师升级和新员工股权授予盘中飙升5.87%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}